Agency Information Collection Activities: Proposed Collection; Comments Requested, 11968 [E9-6054]
Download as PDF
11968
Federal Register / Vol. 74, No. 53 / Friday, March 20, 2009 / Notices
By order of the Commission.
Issued: March 16, 2009.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E9–6129 Filed 3–19–09; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0037]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested
ACTION: 30-day notice of information
collection under review.
Prescription Drug Monitoring Program
Questionnaire
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA) will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 74, Number 8, page
1709, on, January 13, 2009, allowing for
a 60 day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until April 20, 2009. This
process is conducted in accordance with
5 CFR 1320.10. Written comments and/
or suggestions regarding the items
contained in this notice, especially the
estimated public burden and associated
response time, should be directed to the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–5806.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
VerDate Nov<24>2008
17:07 Mar 19, 2009
Jkt 217001
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of Information Collection
1117–0037:
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Prescription Drug Monitoring Program
Questionnaire.
(3) Agency Form Number, if Any, and
the Applicable Component of the
Department of Justice Sponsoring the
Collection: Form Number: None. Office
of Diversion Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: States.
Other: None.
Abstract: This questionnaire permits
the Drug Enforcement Administration to
compile and evaluate information
regarding the design, implementation
and operation of State prescription
monitoring programs. Such information
allows DEA to assist states in the
development of new programs designed
to enhance the ability of both DEA and
State authorities to prevent, detect, and
investigate the diversion and abuse of
controlled substances.
(5) An Estimate of the Total Number
of Respondents and the Amount of Time
Estimated for an Average Respondent to
Respond: It is estimated that 51 persons
complete the Prescription Monitoring
Program Questionnaire electronically, at
5 hours per form, for an annual burden
of 255 hours.
(6) An Estimate of the Total Public
Burden (in Hours) Associated With the
Collection: It is estimated that there are
255 burden hours associated with this
collection.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street NW.,
Washington, DC 20530.
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Dated: March 11, 2009.
Lynn Bryant,
Department Clearance Officer, United States
Department of Justice.
[FR Doc. E9–6054 Filed 3–19–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
National Institute of Corrections
Solicitation for a Cooperative
Agreement—Direct Supervision:
Curriculum Development
AGENCY: National Institute of
Corrections, Department of Justice.
ACTION: Solicitation for a cooperative
agreement.
SUMMARY: The National Institute of
Corrections, Jails Division, is seeking
applications for the development of two
training-program curricula: one that
focuses on the role of the housing-unit
officer and shift supervisor in a direct
supervision jail and another that focuses
on the role of the administrator in a
direct supervision jail. The project will
be for an eighteen-month period, and
will be carried out in conjunction with
the NIC Jails Division. NIC Jails Division
staff will direct the project and will
participate in curriculum design, lesson
plan development, and the creation of
related training materials.
DATES: Applications must be received
by 4 p.m. (EDT) on Friday, April 10,
2009.
ADDRESSES: Mailed applications must be
sent to: Director, National Institute of
Corrections, 320 First Street, NW., Room
5007, Washington, DC 20534.
Applicants are encouraged to use
Federal Express, UPS, or a similar
service to ensure delivery by the due
date, as mail at NIC is sometimes
delayed due to security screening.
Applicants who wish to hand-deliver
their applications should bring them to
500 First Street, NW., Washington, DC
20534 and dial (202) 307–3106, ext. 0 at
the front desk for pickup.
Faxed or e-mailed applications will
not be accepted.
FOR FURTHER INFORMATION CONTACT: A
copy of this announcement and the
required application forms can be
downloaded from the NIC Web page at
https://www.nicic.gov.
All technical or programmatic
questions concerning this
announcement should be directed to
Robbye Braxton-Mintz, Correctional
Program Specialist, National Institute of
Corrections. She can reached by calling
1–800–995–6423 ext. 4–4562 or by email at rbraxtonmintz@bop.gov.
E:\FR\FM\20MRN1.SGM
20MRN1
Agencies
[Federal Register Volume 74, Number 53 (Friday, March 20, 2009)]
[Notices]
[Page 11968]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-6054]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0037]
Agency Information Collection Activities: Proposed Collection;
Comments Requested
ACTION: 30-day notice of information collection under review.
-----------------------------------------------------------------------
Prescription Drug Monitoring Program Questionnaire
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA) will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. This proposed information collection was
previously published in the Federal Register Volume 74, Number 8, page
1709, on, January 13, 2009, allowing for a 60 day comment period.
The purpose of this notice is to allow for an additional 30 days
for public comment until April 20, 2009. This process is conducted in
accordance with 5 CFR 1320.10. Written comments and/or suggestions
regarding the items contained in this notice, especially the estimated
public burden and associated response time, should be directed to the
Office of Management and Budget, Office of Information and Regulatory
Affairs, Attention Department of Justice Desk Officer, Washington, DC
20503. Additionally, comments may be submitted to OMB via facsimile to
(202) 395-5806.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
Evaluate the accuracy of the agencies estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used;
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Overview of Information Collection 1117-0037:
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: Prescription Drug Monitoring
Program Questionnaire.
(3) Agency Form Number, if Any, and the Applicable Component of the
Department of Justice Sponsoring the Collection: Form Number: None.
Office of Diversion Control, Drug Enforcement Administration,
Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: States.
Other: None.
Abstract: This questionnaire permits the Drug Enforcement
Administration to compile and evaluate information regarding the
design, implementation and operation of State prescription monitoring
programs. Such information allows DEA to assist states in the
development of new programs designed to enhance the ability of both DEA
and State authorities to prevent, detect, and investigate the diversion
and abuse of controlled substances.
(5) An Estimate of the Total Number of Respondents and the Amount
of Time Estimated for an Average Respondent to Respond: It is estimated
that 51 persons complete the Prescription Monitoring Program
Questionnaire electronically, at 5 hours per form, for an annual burden
of 255 hours.
(6) An Estimate of the Total Public Burden (in Hours) Associated
With the Collection: It is estimated that there are 255 burden hours
associated with this collection.
If additional information is required contact: Lynn Bryant,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street NW., Washington, DC 20530.
Dated: March 11, 2009.
Lynn Bryant,
Department Clearance Officer, United States Department of Justice.
[FR Doc. E9-6054 Filed 3-19-09; 8:45 am]
BILLING CODE 4410-09-P